{"disease":{"id":"risky-baby","name":"risky baby"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07063966","title":"Are Developmentally At Risky Babies Environmentally Disadvantaged?","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":52,"lead_sponsor_name":"Abant Izzet Baysal University","has_results":false},{"nct_id":"NCT07499843","title":"Synchronous vs. Asynchronous Telerehabilitation for High-Risk Infants","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"Biruni University","has_results":false},{"nct_id":"NCT07534748","title":"Short-term Neonatal and Parental Outcomes in Low- and High-Risk Infants","phase":"NA","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Inonu University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}